Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A prognostic human brain network for diffuse midline glioma.

Nature·2026
Same author

Tempered Optimism: Advances in the Precision Medicine Era for Pediatric Low-Grade Glioma.

Neuro-oncology·2026
Same author

Spliceosome induction is a druggable dependency of RAS-driven senescence and cancer.

Nature communications·2026
Same author

Long-term outcomes of paediatric craniopharyngiomas: a comparison of two large international series.

Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery·2026
Same author

Impaired splicing machinery in craniopharyngiomas unveils PRPF8 and RAVER1 as novel biomarkers and therapeutic targets.

Acta neuropathologica communications·2025
Same author

Conditional Pten inactivation in pituitary results in sex-specific prolactinoma formation.

Biochimica et biophysica acta. Molecular basis of disease·2024

Related Experiment Video

Updated: May 13, 2026

Modeling Astrocytoma Pathogenesis In Vitro and In Vivo Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice
10:13

Modeling Astrocytoma Pathogenesis In Vitro and In Vivo Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice

Published on: August 12, 2014

13.9K

Decoding craniopharyngioma: From mechanisms to therapy.

Jose Mario Gonzalez-Meljem1, Lei Cao2, John Richard Apps3

  • 1Tecnologico de Monterrey, School of Engineering and Sciences, Mexico City, Mexico.

Best Practice & Research. Clinical Endocrinology & Metabolism
|October 12, 2025
PubMed
Summary

Recent craniopharyngioma research decodes subtypes, revealing senescence-driven pathogenesis in adamantinomatous craniopharyngioma (ACP) and BRAF mutations in papillary craniopharyngioma (PCP). This advances targeted therapies for improved patient outcomes.

Keywords:
MAPK inhibitorscellular senescencecraniopharyngiomasenolytics

More Related Videos

Intranasal Delivery of Therapeutic Stem Cells to Glioblastoma in a Mouse Model
09:57

Intranasal Delivery of Therapeutic Stem Cells to Glioblastoma in a Mouse Model

Published on: June 4, 2017

12.7K
Role of Diffusion MRI Tractography in Endoscopic Endonasal Skull Base Surgery
09:53

Role of Diffusion MRI Tractography in Endoscopic Endonasal Skull Base Surgery

Published on: July 5, 2021

4.1K

Related Experiment Videos

Last Updated: May 13, 2026

Modeling Astrocytoma Pathogenesis In Vitro and In Vivo Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice
10:13

Modeling Astrocytoma Pathogenesis In Vitro and In Vivo Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice

Published on: August 12, 2014

13.9K
Intranasal Delivery of Therapeutic Stem Cells to Glioblastoma in a Mouse Model
09:57

Intranasal Delivery of Therapeutic Stem Cells to Glioblastoma in a Mouse Model

Published on: June 4, 2017

12.7K
Role of Diffusion MRI Tractography in Endoscopic Endonasal Skull Base Surgery
09:53

Role of Diffusion MRI Tractography in Endoscopic Endonasal Skull Base Surgery

Published on: July 5, 2021

4.1K

Area of Science:

  • Neuro-oncology
  • Molecular biology
  • Tumor microenvironment research

Background:

  • Craniopharyngioma is a complex sellar tumor with distinct subtypes.
  • Recent research has elucidated the genetic drivers and pathogenesis of these subtypes.

Purpose of the Study:

  • To summarize recent advancements in understanding craniopharyngioma subtypes.
  • To highlight the translation of these findings into novel therapeutic strategies.

Main Methods:

  • Genetic and histological subtyping (adamantinomatous craniopharyngioma [ACP] and papillary craniopharyngioma [PCP]).
  • Development of ACP mouse models and human studies.
  • Single-cell RNA sequencing to analyze tumor ecosystems.

Main Results:

  • ACP is linked to CTNNB1 mutations and WNT pathway activation.
  • PCP is characterized by BRAF-V600E mutations.
  • Senescence-driven pathogenesis in ACP involves paracrine signaling, creating a tumor-promoting microenvironment.

Conclusions:

  • Foundational insights into craniopharyngioma biology are paving the way for targeted therapies.
  • BRAF/MEK inhibitors for PCP and senescence-associated secretory phenotype (SASP) inhibitors for ACP show therapeutic promise.